Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 22.5B | 22.5B | 23.5B | 20.9B |
Cost of revenue | 7.1B | 6.7B | 7.6B | 6.4B |
Gross profit | 15.4B | 15.8B | 16.0B | 14.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 6.1B | 6.3B | 6.5B | 5.7B |
Operating income | 3.3B | 3.6B | 3.4B | 2.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 215.1M | 168.1M | 225.6M | 240.5M |
Other income expense | — | — | — | — |
Pretax income | 1.3B | 3.7B | 3.4B | 2.9B |
Tax provision | 622.2M | 905.9M | 993.9M | 914.1M |
Net income | 639.9M | 2.8B | 2.5B | 2.0B |
Basic EPS | — | 9.8 | 9.1 | 7.6 |
Diluted EPS | — | 9.8 | 9.1 | 7.6 |
Basic average shares | — | 253.7M | 253.6M | 253.6M |
Diluted average shares | — | 253.7M | 253.6M | 253.6M |
EBITDA | 4.5B | 4.8B | 4.7B | 4.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | 38.3M | -282.2M | -162.7M | -69M |
Preferred stock dividends | 0 | 0 | 0 | 0 |